Method for stimulating T lymphocytes with IL-2

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9669071
SERIAL NO

14004211

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ASSISTANCE PUBLIQUE HOPITAUX DE PARIS;UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6);INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bensimon, Gilbert Villejuif, FR 7 56
Bernard, Claude Malakoff, FR 23 590
Cacoub, Patrice Le Perreux, FR 9 62
Klatzmann, David Paris, FR 48 550
Piaggio, Eliane Paris, FR 22 85
Rosenzwajg, Michèle Paris, FR 6 39
Saadoun, David Neuilly sur Seine, FR 7 60

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00